Zusammenfassung
Das postoperative Leberversagen als schwerwiegende Komplikation nach Majorresektionen der Leber geht mit einer hohen Letalität einher. Neben einem zu geringen Restlebervolumen spielen in der Pathophysiologie mehrere weitere Faktoren eine wichtige Rolle. Die entscheidenden Größen sind neben dem Lebervolumen die Leberfunktion, die parenchymatöse Qualität, die Perfusion – gemeint sind der „inflow“ und „outflow“ – und zuletzt der Zustand des Patienten sowie etwaige Komorbiditäten. Während das Lebervolumen relativ einfach mittels moderner Bildgebung zu bestimmen ist, verlangt die Beurteilung der Leberfunktion und der Leberqualität eine differenziertere Betrachtung. Beide Faktoren werden unter anderem konstitutionell, durch Vorerkrankungen sowie Medikationen bestimmt und müssen entsprechende Berücksichtigung bei der Risikoevaluation erfahren. Die Erhaltung einer ausreichenden Perfusion, gemeint ist dabei die portale und arterielle Durchblutung und ein sicherer Abfluss über zumindest eine Lebervene, genauso wie eine sichere bzw. suffiziente biliäre Drainage sind entscheidend für die Regeneration. Nur die Betrachtung und das Verständnis all dieser Kriterien erlauben eine sichere Abschätzung der Resektabilität. Ebenso müssen die peri- und postoperativen Interventionsoptionen bekannt sein und am Standort zur Verfügung stehen. Im folgenden Beitrag werden die wesentlichen Fragen der Risikoevaluierung eines postoperativen Leberversagens aufgezeigt und die therapeutischen Optionen beschrieben. Ziel muss es sein, bei gegebener onkologischer Resektabilität die funktionelle Operabilität herzustellen. Gemeint ist: Stimmt die Indikation, so sollte reseziert werden, was resektabel ist, und resektabel gemacht werden, was primär nicht resektabel erscheint.
Abstract
Posthepatectomy liver failure (PHLF) still represents a severe complication after major liver resection associated with a high mortality. In addition to an insufficient residual liver volume various factors play an important role in the pathophysiology of PHLF. These include the quality of the parenchyma, liver function, perfusion, i.e. maintenance of adequate inflow and outflow, as well as the condition of the patient and comorbidities. While the liver volume is relatively easy to evaluate using modern imaging techniques, the evaluation of liver function and liver quality require a differentiated approach. Both factors can be influenced by the constitutional status of the patient, medical history and previous treatment and must be given sufficient consideration in the risk evaluation. An adequate perfusion, e.g. portal and arterial circulation and adequate outflow by at least one hepatic vein as well an adequate biliary drainage should be always guaranteed in order to allow regeneration of the residual liver tissue. Only the understanding of all these aspects will support the surgeon in a correct and safe evaluation of the resectability. Additionally, the liver surgeon should be aware of all available perioperative and postoperative options to treat and to prevent PHLF. In this review article the most important questions regarding the risk factors related to PHLF are presented and the potential therapeutic and prophylactic management is described. The main goal is to ensure functional operability of the patient if oncological resectability is possible. In other words: in the case of correct oncological indication, the liver surgeon should be able to resect what is resectable or, alternatively, make resectable what primarily was not resectable.
Literatur
Dokmak S, Fteriche FS, Borscheid R, Cauchy F, Farges O, Belghiti J (2013) 2012 liver resections in the 21st century: we are far from zero mortality. HPB (Oxford) 15(11):908–915
Olthof PB, Coelen RJS, Wiggers JK, Groot Koerkamp B, Malago M, Hernandez-Alejandro R et al (2017) High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry. HPB (Oxford) 19(5):381–387
Ray S, Mehta NN, Golhar A, Nundy S (2018) Post hepatectomy liver failure – a comprehensive review of current concepts and controversies. Ann Med Surg (Lond) 34:4–10
Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149(5):713–724
Shoup M, Gonen M, D’Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH et al (2003) Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7(3):325–330
Nadalin S, Capobianco I, Li J, Girotti P, Konigsrainer I, Konigsrainer A (2014) Indications and limits for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Lessons learned from 15 cases at a single centre. Z Gastroenterol 52(1):35–42
Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94(3):274–286
Alizai PH, Haelsig A, Bruners P, Ulmer F, Klink CD, Dejong CHC et al (2018) Impact of liver volume and liver function on posthepatectomy liver failure after portal vein embolization – a multivariable cohort analysis. Ann Med Surg (Lond) 25:6–11
Sotiropoulos GC, Saner FH, Molmenti EP, Radtke A, Timm S, Baba HA et al (2009) Unexpected liver failure after right hemihepatectomy for colorectal liver metastasis due to chemotherapy-associated steato-hepatitis: time for routine preoperative liver biopsy? Int J Colorectal Dis 24(2):241
Allan R, Thoirs K, Phillips M (2010) Accuracy of ultrasound to identify chronic liver disease. World J Gastroenterol 16(28):3510–3520
Cosgrove D, Piscaglia F, Bamber J, Bojunga J, Correas JM, Gilja OH et al (2013) EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. Ultraschall Med 34(3):238–253
Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H et al (2016) Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 150(3):626–637
van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, van Gulik TM et al (2010) Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 256(1):159–168
Vetelainen R, van Vliet A, Gouma DJ, van Gulik TM (2007) Steatosis as a risk factor in liver surgery. Ann Surg 245(1):20–30
Walcott-Sapp S, Billingsley KG (2018) Preoperative optimization for major hepatic resection. Langenbecks Arch Surg 403(1):23–35
Cherqui D, Benoist S, Malassagne B, Humeres R, Rodriguez V, Fagniez PL (2000) Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg 135(3):302–308
Yokoyama Y, Nagino M, Nimura Y (2007) Mechanism of impaired hepatic regeneration in cholestatic liver. J Hepatobiliary Pancreat Surg 14(2):159–166
Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN (2015) Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) 17(8):691–699
Wiggers JK, Groot Koerkamp B, Cieslak KP, Doussot A, van Klaveren D, Allen PJ et al (2016) Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant. J Am Coll Surg 223(2):321–331 e1
Milkiewicz M, Kopycinska J, Kempinska-Podhorodecka A, Haas T, Bogdanos DP, Elias E et al (2014) Ursodeoxycholic acid influences the expression of p27kip1 but not FoxO1 in patients with non-cirrhotic primary biliary cirrhosis. J Immunol Res 2014:921285
Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P et al (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107(5):521–527
Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J et al (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247(1):49–57
Yamashita S, Sakamoto Y, Yamamoto S, Takemura N, Omichi K, Shinkawa H et al (2017) Efficacy of preoperative portal vein embolization among patients with hepatocellular carcinoma, biliary tract cancer, and colorectal liver metastases: a comparative study based on single-center experience of 319 cases. Ann Surg Oncol 24(6):1557–1568
Bismuth H, Adam R, Navarro F, Castaing D, Engerran L, Abascal A (1996) Re-resection for colorectal liver metastasis. Surg Oncol Clin N Am 5(2):353–364
Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P (2004) A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240(6):1037–1049 (discussion 49–51)
Clavien PA, Petrowsky H, DeOliveira ML, Graf R (2007) Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 356(15):1545–1559
Pamecha V, Nedjat-Shokouhi B, Gurusamy K, Glantzounis GK, Sharma D, Davidson BR (2008) Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases. Dig Surg 25(5):387–393
Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA et al (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2‑staged extended right hepatic resection in small-for-size settings. Ann Surg 255(3):405–414
Li J, Girotti P, Konigsrainer I, Ladurner R, Konigsrainer A, Nadalin S (2013) ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure? J Gastrointest Surg 17(5):956–961
Sandstrom P, Rosok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G et al (2018) ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a scandinavian multicenter randomized controlled trial (LIGRO trial). Ann Surg 267(5):833–840
Enne M, Schadde E, Bjornsson B, Hernandez AR, Steinbruck K, Viana E et al (2017) ALPPS as a salvage procedure after insufficient future liver remnant hypertrophy following portal vein occlusion. HPB (Oxford) 19(12):1126–1129
Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N et al (2008) Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 12(2):297–303
Schoen JM, Wang HH, Minuk GY, Lautt WW (2001) Shear stress-induced nitric oxide release triggers the liver regeneration cascade. Nitric Oxide 5(5):453–464
Matsumoto K, Yoshitomi H, Rossant J, Zaret KS (2001) Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294(5542):559–563
Moris D, Vernadakis S, Papalampros A, Vailas M, Dimitrokallis N, Petrou A et al (2016) Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy. World J Gastroenterol 22(33):7613–7624
Dhar DK, Mohammad GH, Vyas S, Broering DC, Malago M (2015) A novel rat model of liver regeneration: possible role of cytokine induced neutrophil chemoattractant-1 in augmented liver regeneration. Ann Surg Innov Res 9:11
Nadalin S, Capobianco I, Konigsrainer A (2015) Vascular management in anatomical liver resection. Chirurg 86(2):121–124
Tomassini F, D’Asseler Y, Giglio MC, Lecluyse C, Lambert B, Sainz-Barriga M et al (2018) Hemodynamic changes in ALPPS influence liver regeneration and function: results from a prospective study. HPB (Oxford). https://doi.org/10.1016/j.hpb.2018.09.005
Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M (2005) Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 12(1):16–22
Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P (2010) The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 12(2):139–146
Cieslak KP, Bennink RJ, de Graaf W, van Lienden KP, Besselink MG, Busch OR et al (2016) Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection. HPB (Oxford) 18(9):773–780
Aloia TA, Fahy BN, Fischer CP, Jones SL, Duchini A, Galati J et al (2009) Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB (Oxford) 11(6):510–515
Rahnemai-Azar AA, Cloyd JM, Weber SM, Dillhoff M, Schmidt C, Winslow ER et al (2018) Update on liver failure following hepatic resection: strategies for prediction and avoidance of post-operative liver insufficiency. J Clin Transl Hepatol 6(1):97–104
Kotewall CN, Cheung TT (2018) Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations. Transl Gastroenterol Hepatol 3:75
Bozzetti F (2002) Rationale and indications for preoperative feeding of malnourished surgical cancer patients. Nutrition 18(11–12):953–959
van den Broek MA, Olde Damink SW, Dejong CH, Lang H, Malago M, Jalan R et al (2008) Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int 28(6):767–780
Weimann A, Braga M, Carli F, Higashiguchi T, Hubner M, Klek S et al (2017) ESPEN guideline: clinical nutrition in surgery. Clin Nutr 36(3):623–650
Melloul E, Hubner M, Scott M, Snowden C, Prentis J, Dejong CH et al (2016) Guidelines for perioperative care for liver surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations. World J Surg 40(10):2425–2440
Alvarado TF, Puliga E, Preziosi M, Poddar M, Singh S, Columbano A et al (2016) Thyroid hormone receptor beta agonist induces beta-catenin-dependent hepatocyte proliferation in mice: implications in hepatic regeneration. Gene Expr 17(1):19–34
Bockhorn M, Fingas CD, Rauen U, Canbay A, Sotiropoulos GC, Frey U et al (2008) Erythropoietin treatment improves liver regeneration and survival in rat models of extended liver resection and living donor liver transplantation. Transplantation 86(11):1578–1585
Petrowsky H, Breitenstein S, Slankamenac K, Vetter D, Lehmann K, Heinrich S et al (2010) Effects of pentoxifylline on liver regeneration: a double-blinded, randomized, controlled trial in 101 patients undergoing major liver resection. Ann Surg 252(5):813–822
Yang L, Kwon J, Popov Y, Gajdos GB, Ordog T, Brekken RA et al (2014) Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. Gastroenterology 146(5):1339–1350 e1
Ramirez-Farias C, Madrigal-Santillan E, Gutierrez-Salinas J, Rodriguez-Sanchez N, Martinez-Cruz M, Valle-Jones I et al (2008) Protective effect of some vitamins against the toxic action of ethanol on liver regeneration induced by partial hepatectomy in rats. World J Gastroenterol 14(6):899–907
Schadde E, Tsatsaris C, Swiderska-Syn M, Breitenstein S, Urner M, Schimmer R et al (2017) Hypoxia of the growing liver accelerates regeneration. Surgery 161(3):666–679
Yagmurdur H, Binnetoglu K, Astarci HM, Yagmurdur MC (2017) Propofol attenuates cytokine-mediated upregulation of expression of inducible nitric oxide synthase and apoptosis during regeneration post-partial hepatectomy. Acta Cir Bras 32(5):396–406
Bilir BM, Guinette D, Karrer F, Kumpe DA, Krysl J, Stephens J et al (2000) Hepatocyte transplantation in acute liver failure. Liver Transpl 6(1):32–40
am Esch JS, Schmelzle M, Furst G, Robson SC, Krieg A, Duhme C et al (2012) Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study. Ann Surg 255(1):79–85
Chen X, Zhao Y, Wang F, Bei Y, Xiao J, Yang C (2015) MicroRNAs in liver regeneration. Cell Physiol Biochem 37(2):615–628
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
I. Capobianco, J. Strohäker, A. Della Penna, S. Nadalin und A. Königsrainer geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Rights and permissions
About this article
Cite this article
Capobianco, I., Strohäker, J., Della Penna, A. et al. Präkonditionierung der Leber. Chirurg 90, 542–547 (2019). https://doi.org/10.1007/s00104-019-0926-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-019-0926-0